Sphingosomal vincristine plus rituximab for treatment of large B-cell lymphoma.

被引：0
|
作者：
Ashcroft, AJ
Kaplan, LD
Damon, LE
Morgan, GJ
机构：
[1] Univ Leeds, Acad Unit Haematol & Oncol, Leeds, W Yorkshire, England
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1454
引用
收藏
页码：400A / 401A
页数：2
相关论文
共 50 条
  • [41] Bendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma
    Kayoko Murayama
    Toru Kiguchi
    Koji Izutsu
    Yoshihiro Kameoka
    Michihiro Hidaka
    Harumi Kato
    Shinya Rai
    Junya Kuroda
    Kenichi Ishizawa
    Satoshi Ichikawa
    Kiyoshi Ando
    Michinori Ogura
    Koji Fukushima
    Yasuhito Terui
    Annals of Hematology, 2022, 101 : 979 - 989
  • [42] Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
    Candelaria, Myrna
    Duenas-Gonzalez, Alfonso
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [43] The molecular rationale for the combination of polatuzumab vedotin plus rituximab in diffuse large B-cell lymphoma
    Kawasaki, Natsumi
    Nishito, Yukari
    Yoshimura, Yasushi
    Yoshiura, Shigeki
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (02) : 245 - 255
  • [44] The Efficacy and Safety of Lenalidomide plus Rituximab in an Orbital Relapse of Diffuse Large B-Cell Lymphoma
    Palmieri, R.
    Esposito, F.
    Meconi, F.
    Rapisarda, V. M.
    Anemona, L.
    Paterno, G.
    Vaccarini, S.
    Nasso, D.
    Pupo, L.
    Cantonetti, M.
    CASE REPORTS IN HEMATOLOGY, 2019, 2019
  • [45] Bendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma
    Murayama, Kayoko
    Kiguchi, Toru
    Izutsu, Koji
    Kameoka, Yoshihiro
    Hidaka, Michihiro
    Kato, Harumi
    Rai, Shinya
    Kuroda, Junya
    Ishizawa, Kenichi
    Ichikawa, Satoshi
    Ando, Kiyoshi
    Ogura, Michinori
    Fukushima, Koji
    Terui, Yasuhito
    ANNALS OF HEMATOLOGY, 2022, 101 (05) : 979 - 989
  • [46] Conditional survival of patients with diffuse large B-cell lymphoma.
    Moller, MB
    Pedersen, NT
    Christensen, BE
    BLOOD, 2005, 106 (11) : 542A - 542A
  • [47] Efficacy and Toxicity of 2 Schedules of Frontline Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Plus Bortezomib in Patients With B-Cell Lymphoma
    Ribrag, Vincent
    Gisselbrecht, Christian
    Haioun, Corinne
    Salles, Gilles
    Golfier, Jean-Baptiste
    Ertault, Marian
    Ferme, Christophe
    Briere, Josette
    Brice, Pauline
    Mounier, Nicolas
    CANCER, 2009, 115 (19) : 4540 - 4546
  • [48] Carcinoma erysipelatoides associated with diffuse large B-cell lymphoma.
    Khan, B. Q.
    Gandhi, M.
    Edmonds, H.
    Ahmad, K.
    Rasberry, R. D.
    Corbett, C. E.
    Jakkola, A. F.
    Carbone, L. C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S313 - S313
  • [49] Favorable outcome in primary mediastinal large B-cell lymphoma.
    Sousa, AB
    Costa, F
    Fernandes, JP
    Sousa, MO
    Ferreira, G
    Bernardo, M
    Gouveia, J
    Gonçalves, AJ
    BLOOD, 2000, 96 (11) : 231B - 231B
  • [50] Rituximab treatment in primary cutaneous B-cell lymphoma
    Estrach, M. Teresa
    Lerma, Ingrid Lopez
    Herrera, Adriana Garcia
    Mascaro, Jose Manuel, Jr.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB138 - AB138
12345